FUNGAL PNEUMONIA

被引:24
|
作者
DAVIES, SF [1 ]
机构
[1] UNIV MINNESOTA,SCH MED,MINNEAPOLIS,MN 55455
关键词
D O I
10.1016/S0025-7125(16)30119-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Fungal pathogens are rare but important causes of pneumonia. They are important because they cause serious infections and can progress to death and because they are untreated by the broad-spectrum antibacterial antibiotics that are used empirically for community-acquired and hospital-acquired pneumonia. Yet they are rare, so initial high suspicion of fungal cause is not appropriate in an ordinary case of pneumonia. There are, however, certain specific details of the clinical illness in some cases of pneumonia that should raise suspicion that a fungal pathogen may be the causative agent. Each fungal pneumonia is discussed separately. Specific clinical clues to each illness are presented first, followed by current strategies for confirming the diagnosis and treating the infection. The separate diseases are organized into two main groups. First are diseases caused by T cell opportunists. Nonimmune phagocytes cannot kill the inhaled spores of these organisms.(25) Specific immunity must be engaged to control the infection. Macrophages must ingest the spores and present specific antigens to T cells. Specific immune T cells must replicate and ''arm'' other macrophages, which then slow fungal growth and wall off the invading fungi within granulomas. The implications of a requirement for specific immunity include (1) all nonimmune subjects can be infected if they inhale the spores; (2) symptoms are variable and depend somewhat on the number of spores inhaled and the magnitude of the immune response; (3) once specific immunity is engaged, the disease tends to be self-limited; and (4) subjects with impaired T cell function are at high risk for severe, rapidly progressive infections. Diseases caused by T cell oppor tunists include histoplasmosis, blastomycosis, coccidioidomycosis, paracoccidioidomycosis, and cryptococcosis. All have high potential for causing severe infections in human immunodeficiency virus (HIV)-infected persons and others with T cell defects, including organ transplant recipients and others treated with high doses of glucocorticoids and with other immunosuppressive therapy for a variety of malignant and nonmalignant disorders. Second are the diseases caused by the phagocyte opportunists. Nonimmune phagocytes, particularly neutrophils, can kill the inhaled spores of these agents.(25)
引用
收藏
页码:1049 / 1065
页数:17
相关论文
共 50 条
  • [41] Organising pneumonia mimicking invasive fungal disease in patients with leukaemia
    Forghieri, Fabio
    Potenza, Leonardo
    Morselli, Monica
    Maccaferri, Monica
    Pedrazzi, Letizia
    Barozzi, Patrizia
    Vallerini, Daniela
    Riva, Giovanni
    Zanetti, Eleonora
    Quadrelli, Chiara
    Rossi, Giulio
    Rivasi, Francesco
    Messino, Massimino
    Rumpianesi, Fabio
    Grottola, Antonella
    Venturelli, Claudia
    Pecorari, Monica
    Codeluppi, Mauro
    Torelli, Giuseppe
    Luppi, Mario
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 85 (01) : 76 - 82
  • [42] Fungal Pneumonia and Pulmonary Embolism in a Child with Refractory Leukemia: Coincidence or Not?
    Kaya, Zuhre
    Yazol, Merve
    Kirkiz, Serap
    Turkcan, Busra Topuz
    Bayramli, Ahmet
    Tezer, Hasan
    Kocak, Ulker
    [J]. INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2024,
  • [43] BACTERIAL, FUNGAL, AND VIRAL PNEUMONIA IN HIV-INFECTED PATIENTS
    HIRSCHTICK, R
    GLASSROTH, J
    [J]. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 16 (03) : 207 - 215
  • [44] Pneumonia and Lung Infections due to Emerging and Unusual Fungal Pathogens
    Chen, Sharon C. -A.
    Blyth, Christopher C.
    Sorrell, Tania C.
    Slavin, Monica A.
    [J]. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 32 (06) : 703 - 716
  • [45] IS INTRATRACHEAL ADMINISTRATION OF NYSTATIN FOR THE PREVENTION OF FUNGAL PNEUMONIA A REASONABLE MEASURE
    TREU, TM
    SCHWARZKOPF, L
    [J]. ZEITSCHRIFT FUR KLINISCHE MEDIZIN-ZKM, 1989, 44 (21): : 1853 - 1855
  • [46] Fungal Pneumonia Caused By Trichosporon Inkin In A Cystic Fibrosis Patient
    Hoeting, N.
    Walker, S.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [47] Fungal Pneumonia in Patients with Hematologic Malignancies and Hematopoietic Cell Transplantation
    Pergam, Steven A.
    [J]. CLINICS IN CHEST MEDICINE, 2017, 38 (02) : 279 - 294
  • [48] Fungal pneumonia in patients with hematologic malignancies: current approach and management
    Mulanovich, Victor E.
    Kontoyiannis, Dimitrios P.
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2011, 24 (04) : 323 - 332
  • [49] Diagnostic and therapeutic approach to fungal pneumonia in the critically ill patient
    Fortun, Jesus
    [J]. REVISTA ESPANOLA DE QUIMIOTERAPIA, 2022, 35 : 97 - 103
  • [50] Fungal Pneumonia - Leptospirosis Co-Infection: A Case Report
    Paranthakan, C.
    Ali, K. Mohamed
    Sangeetha, Sivaraja B.
    Kumaravel, S. Mangaleswari
    [J]. RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES, 2018, 9 (02): : 351 - 353